DATE: June 26, 2019
TIME: 10:00am PDT
Mammalian cell line generation is a rate-limiting step in early CMC development and there is a constant desire to increase throughput. The implementation of automation is one way to increase throughput. This webinar will address some factors to consider during the process of automating a manual workflow including details of culture vessel changes, liquid handling adaptation, and changes of the cell line developer’s job during the process.
With an end result of increased throughput, automation potentially allows cell line development to begin prior to final molecule selection. This can remove cell line development off the critical path of CMC development.
Key Learning Objectives:
Adjustments required to a manual cell line development workflow to evolve into an automated liquid handling workflow
How to optimize pipette tip selection in an automated cell line development workflow
How lab roles evolve with the addition of an automated liquid handler
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
Molecular Biology
Cell Biology
Biotechnology
Cell Culture
Genetics
Immunology
Biology
Microbiology
Cancer Research
Laboratory Testing
Biochemistry
Molecular Diagnostics
Dna
Biomarkers
Antibodies
North America59%
Asia20%
Europe17%
South America2%
Africa2%
Website Visitors46%
Email Promotions37%
WAVE Newsletter Promotion6%
Trending Newsletter Promotion3%
Social Media Promotions1%
Other7%
Medical Laboratory Technician18%
Research Scientist14%
Facility/Department Manager14%
Scientist11%
Student8%
Executive6%
Clinical Laboratory Scientist5%
Medical Doctor/Specialist4%
Post Doc4%
Lab Management4%
Marketing/Sales3%
Biologist2%
Engineer2%
Educator/Faculty2%
QC/QA1%
Consultant1%
Academic Institution20%
Hospital16%
Biotech Company14%
Life Science Company5%
Research Institute4%
Medical Center4%
Clinical Laboratory4%
Distribution/sales4%
Pharmaceutical Company3%
Contract Research Organization (Cro)3%
Non-Profit Organization2%
Government2%
Consultant2%
Independent Laboratories2%
Other4%